nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—CYP3A43—Rifampicin—leprosy	0.349	0.399	CbGbCtD
Zalcitabine—SLC22A7—Rifampicin—leprosy	0.131	0.15	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0509	0.0581	CbGbCtD
Zalcitabine—CYP3A7—Rifampicin—leprosy	0.0509	0.0581	CbGbCtD
Zalcitabine—CYP3A7—Dapsone—leprosy	0.042	0.048	CbGbCtD
Zalcitabine—CYP3A7-CYP3A51P—Dapsone—leprosy	0.042	0.048	CbGbCtD
Zalcitabine—CYP3A5—Thalidomide—leprosy	0.0394	0.045	CbGbCtD
Zalcitabine—CYP3A5—Rifampicin—leprosy	0.0382	0.0436	CbGbCtD
Zalcitabine—CYP3A5—Dapsone—leprosy	0.0315	0.036	CbGbCtD
Zalcitabine—CYP2C9—Thalidomide—leprosy	0.0264	0.0302	CbGbCtD
Zalcitabine—CYP2C9—Rifampicin—leprosy	0.0256	0.0292	CbGbCtD
Zalcitabine—CYP2C9—Dapsone—leprosy	0.0211	0.0241	CbGbCtD
Zalcitabine—CYP3A4—Rifampicin—leprosy	0.0149	0.017	CbGbCtD
Zalcitabine—CYP3A4—Dapsone—leprosy	0.0123	0.014	CbGbCtD
Zalcitabine—Gingival disorder—Thalidomide—leprosy	0.00846	0.0696	CcSEcCtD
Zalcitabine—Status epilepticus—Thalidomide—leprosy	0.00339	0.0279	CcSEcCtD
Zalcitabine—DCK—Menadione—Thalidomide—leprosy	0.00294	1	CbGdCrCtD
Zalcitabine—Suicide attempt—Dapsone—leprosy	0.00275	0.0226	CcSEcCtD
Zalcitabine—Albuminuria—Dapsone—leprosy	0.00209	0.0172	CcSEcCtD
Zalcitabine—Rales—Thalidomide—leprosy	0.00194	0.016	CcSEcCtD
Zalcitabine—Dementia—Thalidomide—leprosy	0.00194	0.016	CcSEcCtD
Zalcitabine—Neck stiffness—Thalidomide—leprosy	0.00168	0.0138	CcSEcCtD
Zalcitabine—Grand mal convulsion—Thalidomide—leprosy	0.00168	0.0138	CcSEcCtD
Zalcitabine—Nuchal rigidity—Thalidomide—leprosy	0.00154	0.0127	CcSEcCtD
Zalcitabine—Skin exfoliation—Dapsone—leprosy	0.00149	0.0122	CcSEcCtD
Zalcitabine—Suicide attempt—Thalidomide—leprosy	0.00141	0.0116	CcSEcCtD
Zalcitabine—Enlargement abdomen—Thalidomide—leprosy	0.00133	0.0109	CcSEcCtD
Zalcitabine—Toothache—Thalidomide—leprosy	0.00131	0.0108	CcSEcCtD
Zalcitabine—Hypomagnesaemia—Thalidomide—leprosy	0.00126	0.0103	CcSEcCtD
Zalcitabine—Nail disorder—Thalidomide—leprosy	0.00123	0.0101	CcSEcCtD
Zalcitabine—Neuralgia—Thalidomide—leprosy	0.00115	0.00945	CcSEcCtD
Zalcitabine—Hypercalcaemia—Thalidomide—leprosy	0.00115	0.00945	CcSEcCtD
Zalcitabine—Cyanosis—Thalidomide—leprosy	0.00113	0.00928	CcSEcCtD
Zalcitabine—Hepatomegaly—Thalidomide—leprosy	0.00113	0.00928	CcSEcCtD
Zalcitabine—Hyperlipidaemia—Thalidomide—leprosy	0.00111	0.00911	CcSEcCtD
Zalcitabine—Psychotic disorder—Dapsone—leprosy	0.0011	0.00909	CcSEcCtD
Zalcitabine—Albuminuria—Thalidomide—leprosy	0.00107	0.00879	CcSEcCtD
Zalcitabine—Stupor—Thalidomide—leprosy	0.00107	0.00879	CcSEcCtD
Zalcitabine—Neuritis—Thalidomide—leprosy	0.00107	0.00879	CcSEcCtD
Zalcitabine—Skin ulcer—Thalidomide—leprosy	0.00102	0.00843	CcSEcCtD
Zalcitabine—Nasopharyngitis—Dapsone—leprosy	0.00101	0.00833	CcSEcCtD
Zalcitabine—Muscular weakness—Dapsone—leprosy	0.000998	0.00821	CcSEcCtD
Zalcitabine—Pancreatitis—Dapsone—leprosy	0.000959	0.00789	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Dapsone—leprosy	0.000892	0.00734	CcSEcCtD
Zalcitabine—Musculoskeletal stiffness—Thalidomide—leprosy	0.000889	0.00732	CcSEcCtD
Zalcitabine—Arthropathy—Thalidomide—leprosy	0.000877	0.00722	CcSEcCtD
Zalcitabine—Cellulitis—Thalidomide—leprosy	0.000877	0.00722	CcSEcCtD
Zalcitabine—Hyperbilirubinaemia—Thalidomide—leprosy	0.000877	0.00722	CcSEcCtD
Zalcitabine—Hypocalcaemia—Thalidomide—leprosy	0.000871	0.00717	CcSEcCtD
Zalcitabine—Hyperuricaemia—Thalidomide—leprosy	0.00086	0.00708	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Dapsone—leprosy	0.000855	0.00703	CcSEcCtD
Zalcitabine—Creatinine increased—Thalidomide—leprosy	0.000838	0.0069	CcSEcCtD
Zalcitabine—Hearing impaired—Thalidomide—leprosy	0.000838	0.0069	CcSEcCtD
Zalcitabine—Sinusitis—Dapsone—leprosy	0.000818	0.00673	CcSEcCtD
Zalcitabine—Coordination abnormal—Thalidomide—leprosy	0.000812	0.00669	CcSEcCtD
Zalcitabine—Blood uric acid increased—Thalidomide—leprosy	0.000812	0.00669	CcSEcCtD
Zalcitabine—Neck pain—Thalidomide—leprosy	0.000807	0.00665	CcSEcCtD
Zalcitabine—Hepatocellular injury—Thalidomide—leprosy	0.000798	0.00657	CcSEcCtD
Zalcitabine—Phosphatase alkaline increased—Thalidomide—leprosy	0.000798	0.00657	CcSEcCtD
Zalcitabine—Hyperkalaemia—Thalidomide—leprosy	0.000784	0.00645	CcSEcCtD
Zalcitabine—Eructation—Thalidomide—leprosy	0.000784	0.00645	CcSEcCtD
Zalcitabine—Pharyngitis—Dapsone—leprosy	0.000777	0.00639	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Thalidomide—leprosy	0.00077	0.00634	CcSEcCtD
Zalcitabine—Colitis—Thalidomide—leprosy	0.000766	0.0063	CcSEcCtD
Zalcitabine—Candida infection—Thalidomide—leprosy	0.000762	0.00627	CcSEcCtD
Zalcitabine—Skin exfoliation—Thalidomide—leprosy	0.000762	0.00627	CcSEcCtD
Zalcitabine—Blood urea increased—Thalidomide—leprosy	0.000753	0.0062	CcSEcCtD
Zalcitabine—Dry eye—Thalidomide—leprosy	0.000737	0.00606	CcSEcCtD
Zalcitabine—Cramps of lower extremities—Thalidomide—leprosy	0.000733	0.00603	CcSEcCtD
Zalcitabine—Tinnitus—Dapsone—leprosy	0.00073	0.00601	CcSEcCtD
Zalcitabine—Oesophagitis—Thalidomide—leprosy	0.000729	0.006	CcSEcCtD
Zalcitabine—Rash maculo-papular—Thalidomide—leprosy	0.000725	0.00597	CcSEcCtD
Zalcitabine—Hypertonia—Thalidomide—leprosy	0.000699	0.00576	CcSEcCtD
Zalcitabine—Hyperkinesia—Thalidomide—leprosy	0.000696	0.00573	CcSEcCtD
Zalcitabine—Mental disability—Thalidomide—leprosy	0.000692	0.0057	CcSEcCtD
Zalcitabine—Euphoric mood—Thalidomide—leprosy	0.000685	0.00564	CcSEcCtD
Zalcitabine—Lymphadenopathy—Thalidomide—leprosy	0.000679	0.00559	CcSEcCtD
Zalcitabine—Diabetes mellitus—Thalidomide—leprosy	0.000666	0.00548	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000666	0.00548	CcSEcCtD
Zalcitabine—Deafness—Thalidomide—leprosy	0.000647	0.00533	CcSEcCtD
Zalcitabine—Vascular purpura—Thalidomide—leprosy	0.000647	0.00533	CcSEcCtD
Zalcitabine—Vision blurred—Dapsone—leprosy	0.000642	0.00528	CcSEcCtD
Zalcitabine—Eye pain—Thalidomide—leprosy	0.000641	0.00528	CcSEcCtD
Zalcitabine—Renal failure acute—Thalidomide—leprosy	0.000627	0.00516	CcSEcCtD
Zalcitabine—Libido decreased—Thalidomide—leprosy	0.000624	0.00514	CcSEcCtD
Zalcitabine—Amnesia—Thalidomide—leprosy	0.000616	0.00507	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Thalidomide—leprosy	0.000614	0.00505	CcSEcCtD
Zalcitabine—Vertigo—Dapsone—leprosy	0.000612	0.00504	CcSEcCtD
Zalcitabine—Atrial fibrillation—Thalidomide—leprosy	0.000611	0.00503	CcSEcCtD
Zalcitabine—Dermatitis bullous—Thalidomide—leprosy	0.000606	0.00499	CcSEcCtD
Zalcitabine—Purpura—Thalidomide—leprosy	0.000601	0.00494	CcSEcCtD
Zalcitabine—Arthritis—Thalidomide—leprosy	0.000596	0.0049	CcSEcCtD
Zalcitabine—Cough—Dapsone—leprosy	0.000594	0.00489	CcSEcCtD
Zalcitabine—Hypoglycaemia—Thalidomide—leprosy	0.000593	0.00488	CcSEcCtD
Zalcitabine—Cardiac failure—Thalidomide—leprosy	0.000593	0.00488	CcSEcCtD
Zalcitabine—Hyponatraemia—Thalidomide—leprosy	0.000581	0.00479	CcSEcCtD
Zalcitabine—Osteoarthritis—Thalidomide—leprosy	0.000579	0.00477	CcSEcCtD
Zalcitabine—Pain in extremity—Thalidomide—leprosy	0.000579	0.00477	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000579	0.00477	CcSEcCtD
Zalcitabine—Disturbance in sexual arousal—Thalidomide—leprosy	0.000575	0.00473	CcSEcCtD
Zalcitabine—Migraine—Thalidomide—leprosy	0.00057	0.00469	CcSEcCtD
Zalcitabine—Affect lability—Thalidomide—leprosy	0.00057	0.00469	CcSEcCtD
Zalcitabine—Psychotic disorder—Thalidomide—leprosy	0.000566	0.00465	CcSEcCtD
Zalcitabine—Mood swings—Thalidomide—leprosy	0.000549	0.00451	CcSEcCtD
Zalcitabine—Ataxia—Thalidomide—leprosy	0.000545	0.00448	CcSEcCtD
Zalcitabine—Tachycardia—Dapsone—leprosy	0.000543	0.00447	CcSEcCtD
Zalcitabine—Blood creatinine increased—Thalidomide—leprosy	0.000543	0.00446	CcSEcCtD
Zalcitabine—Dry skin—Thalidomide—leprosy	0.000531	0.00437	CcSEcCtD
Zalcitabine—Hypokalaemia—Thalidomide—leprosy	0.000527	0.00434	CcSEcCtD
Zalcitabine—Cramp muscle—Thalidomide—leprosy	0.000521	0.00429	CcSEcCtD
Zalcitabine—Muscular weakness—Thalidomide—leprosy	0.000511	0.0042	CcSEcCtD
Zalcitabine—Abdominal distension—Thalidomide—leprosy	0.000504	0.00415	CcSEcCtD
Zalcitabine—Insomnia—Dapsone—leprosy	0.000503	0.00414	CcSEcCtD
Zalcitabine—Dysphagia—Thalidomide—leprosy	0.000501	0.00412	CcSEcCtD
Zalcitabine—Eosinophilia—Thalidomide—leprosy	0.000496	0.00408	CcSEcCtD
Zalcitabine—Pancreatitis—Thalidomide—leprosy	0.000491	0.00404	CcSEcCtD
Zalcitabine—Neutropenia—Thalidomide—leprosy	0.000468	0.00385	CcSEcCtD
Zalcitabine—Pollakiuria—Thalidomide—leprosy	0.000462	0.00381	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Thalidomide—leprosy	0.000457	0.00376	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Dapsone—leprosy	0.000455	0.00374	CcSEcCtD
Zalcitabine—Weight decreased—Thalidomide—leprosy	0.000453	0.00373	CcSEcCtD
Zalcitabine—Hyperglycaemia—Thalidomide—leprosy	0.000451	0.00372	CcSEcCtD
Zalcitabine—Depression—Thalidomide—leprosy	0.000445	0.00366	CcSEcCtD
Zalcitabine—Abdominal pain—Dapsone—leprosy	0.00044	0.00362	CcSEcCtD
Zalcitabine—Body temperature increased—Dapsone—leprosy	0.00044	0.00362	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Thalidomide—leprosy	0.000437	0.0036	CcSEcCtD
Zalcitabine—Epistaxis—Thalidomide—leprosy	0.000421	0.00346	CcSEcCtD
Zalcitabine—Sinusitis—Thalidomide—leprosy	0.000419	0.00345	CcSEcCtD
Zalcitabine—Rhinitis—Thalidomide—leprosy	0.000402	0.00331	CcSEcCtD
Zalcitabine—Hepatitis—Thalidomide—leprosy	0.000401	0.0033	CcSEcCtD
Zalcitabine—Pharyngitis—Thalidomide—leprosy	0.000398	0.00327	CcSEcCtD
Zalcitabine—Visual impairment—Thalidomide—leprosy	0.000386	0.00318	CcSEcCtD
Zalcitabine—Eye disorder—Thalidomide—leprosy	0.000374	0.00308	CcSEcCtD
Zalcitabine—Tinnitus—Thalidomide—leprosy	0.000374	0.00307	CcSEcCtD
Zalcitabine—Chills—Thalidomide—leprosy	0.000359	0.00296	CcSEcCtD
Zalcitabine—Arrhythmia—Thalidomide—leprosy	0.000358	0.00295	CcSEcCtD
Zalcitabine—Alopecia—Thalidomide—leprosy	0.000354	0.00291	CcSEcCtD
Zalcitabine—Vomiting—Dapsone—leprosy	0.000354	0.00291	CcSEcCtD
Zalcitabine—Headache—Dapsone—leprosy	0.000348	0.00287	CcSEcCtD
Zalcitabine—Flatulence—Thalidomide—leprosy	0.000344	0.00283	CcSEcCtD
Zalcitabine—Tension—Thalidomide—leprosy	0.000342	0.00282	CcSEcCtD
Zalcitabine—Dysgeusia—Thalidomide—leprosy	0.000342	0.00281	CcSEcCtD
Zalcitabine—Nervousness—Thalidomide—leprosy	0.000339	0.00279	CcSEcCtD
Zalcitabine—Back pain—Thalidomide—leprosy	0.000337	0.00278	CcSEcCtD
Zalcitabine—Muscle spasms—Thalidomide—leprosy	0.000335	0.00276	CcSEcCtD
Zalcitabine—Vision blurred—Thalidomide—leprosy	0.000329	0.0027	CcSEcCtD
Zalcitabine—Tremor—Thalidomide—leprosy	0.000327	0.00269	CcSEcCtD
Zalcitabine—Ill-defined disorder—Thalidomide—leprosy	0.000324	0.00266	CcSEcCtD
Zalcitabine—Anaemia—Thalidomide—leprosy	0.000322	0.00265	CcSEcCtD
Zalcitabine—Agitation—Thalidomide—leprosy	0.00032	0.00264	CcSEcCtD
Zalcitabine—Malaise—Thalidomide—leprosy	0.000314	0.00259	CcSEcCtD
Zalcitabine—Vertigo—Thalidomide—leprosy	0.000313	0.00258	CcSEcCtD
Zalcitabine—Syncope—Thalidomide—leprosy	0.000313	0.00257	CcSEcCtD
Zalcitabine—Leukopenia—Thalidomide—leprosy	0.000312	0.00257	CcSEcCtD
Zalcitabine—Palpitations—Thalidomide—leprosy	0.000308	0.00254	CcSEcCtD
Zalcitabine—Loss of consciousness—Thalidomide—leprosy	0.000307	0.00252	CcSEcCtD
Zalcitabine—Cough—Thalidomide—leprosy	0.000304	0.0025	CcSEcCtD
Zalcitabine—Convulsion—Thalidomide—leprosy	0.000302	0.00249	CcSEcCtD
Zalcitabine—Hypertension—Thalidomide—leprosy	0.000301	0.00248	CcSEcCtD
Zalcitabine—Arthralgia—Thalidomide—leprosy	0.000297	0.00244	CcSEcCtD
Zalcitabine—Myalgia—Thalidomide—leprosy	0.000297	0.00244	CcSEcCtD
Zalcitabine—Anxiety—Thalidomide—leprosy	0.000296	0.00244	CcSEcCtD
Zalcitabine—Discomfort—Thalidomide—leprosy	0.000293	0.00241	CcSEcCtD
Zalcitabine—Dry mouth—Thalidomide—leprosy	0.00029	0.00239	CcSEcCtD
Zalcitabine—Confusional state—Thalidomide—leprosy	0.000287	0.00236	CcSEcCtD
Zalcitabine—Oedema—Thalidomide—leprosy	0.000285	0.00234	CcSEcCtD
Zalcitabine—Infection—Thalidomide—leprosy	0.000283	0.00233	CcSEcCtD
Zalcitabine—Shock—Thalidomide—leprosy	0.00028	0.0023	CcSEcCtD
Zalcitabine—Thrombocytopenia—Thalidomide—leprosy	0.000279	0.00229	CcSEcCtD
Zalcitabine—Tachycardia—Thalidomide—leprosy	0.000278	0.00229	CcSEcCtD
Zalcitabine—Skin disorder—Thalidomide—leprosy	0.000276	0.00228	CcSEcCtD
Zalcitabine—Hyperhidrosis—Thalidomide—leprosy	0.000275	0.00226	CcSEcCtD
Zalcitabine—Anorexia—Thalidomide—leprosy	0.000271	0.00223	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Thalidomide—leprosy	0.000259	0.00213	CcSEcCtD
Zalcitabine—Insomnia—Thalidomide—leprosy	0.000257	0.00212	CcSEcCtD
Zalcitabine—Dyspnoea—Thalidomide—leprosy	0.000254	0.00209	CcSEcCtD
Zalcitabine—Somnolence—Thalidomide—leprosy	0.000253	0.00208	CcSEcCtD
Zalcitabine—Dyspepsia—Thalidomide—leprosy	0.000251	0.00206	CcSEcCtD
Zalcitabine—Decreased appetite—Thalidomide—leprosy	0.000247	0.00204	CcSEcCtD
Zalcitabine—Fatigue—Thalidomide—leprosy	0.000245	0.00202	CcSEcCtD
Zalcitabine—Pain—Thalidomide—leprosy	0.000243	0.002	CcSEcCtD
Zalcitabine—Feeling abnormal—Thalidomide—leprosy	0.000235	0.00193	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Thalidomide—leprosy	0.000233	0.00192	CcSEcCtD
Zalcitabine—Urticaria—Thalidomide—leprosy	0.000226	0.00186	CcSEcCtD
Zalcitabine—Body temperature increased—Thalidomide—leprosy	0.000225	0.00185	CcSEcCtD
Zalcitabine—Abdominal pain—Thalidomide—leprosy	0.000225	0.00185	CcSEcCtD
Zalcitabine—Hypersensitivity—Thalidomide—leprosy	0.00021	0.00173	CcSEcCtD
Zalcitabine—Asthenia—Thalidomide—leprosy	0.000204	0.00168	CcSEcCtD
Zalcitabine—Pruritus—Thalidomide—leprosy	0.000201	0.00166	CcSEcCtD
Zalcitabine—Diarrhoea—Thalidomide—leprosy	0.000195	0.0016	CcSEcCtD
Zalcitabine—Dizziness—Thalidomide—leprosy	0.000188	0.00155	CcSEcCtD
Zalcitabine—Vomiting—Thalidomide—leprosy	0.000181	0.00149	CcSEcCtD
Zalcitabine—Rash—Thalidomide—leprosy	0.000179	0.00148	CcSEcCtD
Zalcitabine—Dermatitis—Thalidomide—leprosy	0.000179	0.00148	CcSEcCtD
Zalcitabine—Headache—Thalidomide—leprosy	0.000178	0.00147	CcSEcCtD
